{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T02:32:52Z","timestamp":1777429972490,"version":"3.51.4"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,17]],"date-time":"2024-11-17T00:00:00Z","timestamp":1731801600000},"content-version":"am","delay-in-days":321,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003993","name":"Ministry of Agriculture, Forestry and Fisheries","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003993","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["JPJ008837"],"award-info":[{"award-number":["JPJ008837"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Tropica"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.actatropica.2023.107069","type":"journal-article","created":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T13:45:05Z","timestamp":1699623905000},"page":"107069","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Anti-babesial activity of a series of 6,7-dimethoxyquinazoline-2,4-diamines (DMQDAs)"],"prefix":"10.1016","volume":"249","author":[{"given":"Shengwei","family":"Ji","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed Abdo","family":"Rizk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eloiza May","family":"Galon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"El-Sayed","family":"El-Alfy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Mizukawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayoshi","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayumi","family":"Ikegami-Kawai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motohiro","family":"Kaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isamu","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2780-110X","authenticated-orcid":false,"given":"Xuenan","family":"Xuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.actatropica.2023.107069_bib0001","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.ejmech.2018.03.076","article-title":"An overview of quinazolines: pharmacological significance and recent developments","volume":"151","author":"Alagarsamy","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.actatropica.2023.107069_bib0002","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.tube.2009.05.008","article-title":"High-throughput screening for inhibitors of Mycobacterium tuberculosis H37Rv","volume":"89","author":"Ananthan","year":"2009","journal-title":"Tuberculosis"},{"key":"10.1016\/j.actatropica.2023.107069_bib0003","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1359-6446(04)03308-2","article-title":"Targeting DHFR in parasitic protozoa","volume":"10","author":"Anderson","year":"2005","journal-title":"Drug Discov. Today."},{"key":"10.1016\/j.actatropica.2023.107069_bib0004","doi-asserted-by":"crossref","DOI":"10.1002\/med.21975","article-title":"Chemo-proteomics in antimalarial target identification and engagement","author":"Bailey","year":"2023","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.actatropica.2023.107069_bib0005","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.vetpar.2018.03.001","article-title":"Antiprotozoal treatment of canine babesiosis","volume":"254","author":"Baneth","year":"2018","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.actatropica.2023.107069_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.113016","article-title":"Therapeutic progression of quinazolines as targeted chemotherapeutic agents","volume":"211","author":"Bansal","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.actatropica.2023.107069_bib0007","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1107\/S1744309111029009","article-title":"Inhibitor-bound complexes of dihydrofolate reductase-thymidylate synthase from Babesia bovis","volume":"67","author":"Begley","year":"2011","journal-title":"Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun."},{"key":"10.1016\/j.actatropica.2023.107069_bib0008","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.lfs.2016.06.030","article-title":"Understanding the biology of the Plasmodium falciparum apicoplast; an excellent target for antimalarial drug development","volume":"158","author":"Chakraborty","year":"2016","journal-title":"Life Sci."},{"key":"10.1016\/j.actatropica.2023.107069_bib0009","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13148-015-0118-9","article-title":"Dual EZH2 and EHMT2 histone methyltransferase inhibition increases biological efficacy in breast cancer cells","volume":"7","author":"Curry","year":"2015","journal-title":"Clin. Epigenetics."},{"key":"10.1016\/j.actatropica.2023.107069_bib0010","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1128\/AAC.00527-07","article-title":"Multiple antibiotics exert delayed effects against the Plasmodium falciparum apicoplast","volume":"51","author":"Dahl","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actatropica.2023.107069_bib0011","doi-asserted-by":"crossref","first-page":"6574","DOI":"10.3390\/molecules27196574","article-title":"Preliminary structure\u2013activity relationship study of the MMV pathogen box compound MMV675968 (2, 4-Diaminoquinazoline) unveils novel inhibitors of Trypanosoma brucei brucei","volume":"27","author":"Dize","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.actatropica.2023.107069_bib0012","doi-asserted-by":"crossref","first-page":"609","DOI":"10.2174\/138161207780162827","article-title":"Dihydrofolate reductase as a target for chemotherapy in parasites","volume":"13","author":"Gangjee","year":"2007","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.actatropica.2023.107069_bib0013","doi-asserted-by":"crossref","first-page":"4759","DOI":"10.1016\/j.bmc.2008.02.091","article-title":"Recent advances in selective \u03b11-adrenoreceptor antagonists as antihypertensive agents","volume":"16","author":"Jain","year":"2008","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.actatropica.2023.107069_bib0014","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00574-22","article-title":"Efficacy of the antimalarial MMV390048 against babesia infection reveals phosphatidylinositol 4-kinase as a druggable target for babesiosis","volume":"66","author":"Ji","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actatropica.2023.107069_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13071-021-05127-0","article-title":"Inhibitory effect of naphthoquine phosphate on Babesia gibsoni in vitro and Babesia rodhaini in vivo","volume":"15","author":"Ji","year":"2022","journal-title":"Parasit. Vectors."},{"key":"10.1016\/j.actatropica.2023.107069_bib0016","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ijpara.2018.09.005","article-title":"To kill a piroplasm: genetic technologies to advance drug discovery and target identification in Babesia","volume":"49","author":"Keroack","year":"2019","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.actatropica.2023.107069_bib0017","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1016\/j.bmc.2005.01.025","article-title":"Design, synthesis and evaluation of 2, 4-diaminoquinazolines as inhibitors of trypanosomal and leishmanial dihydrofolate reductase","volume":"13","author":"Khabnadideh","year":"2005","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.actatropica.2023.107069_bib0018","doi-asserted-by":"crossref","DOI":"10.1128\/Spectrum.00739-21","article-title":"Identification of small molecule inhibitors of the pathogen box against vibrio cholerae","volume":"9","author":"Kim","year":"2021","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.actatropica.2023.107069_bib0019","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.molcel.2007.01.017","article-title":"Reversal of H3K9me2 by a small-molecule inhibitor for the G9a histone methyltransferase","volume":"25","author":"Kubicek","year":"2007","journal-title":"Mol. Cell."},{"key":"10.1016\/j.actatropica.2023.107069_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nmicrobiol.2016.79","article-title":"A global map of genetic diversity in Babesia microti reveals strong population structure and identifies variants associated with clinical relapse","volume":"1","author":"Lemieux","year":"2016","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.actatropica.2023.107069_bib0021","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1128\/IAI.05900-11","article-title":"Macrophages are critical for cross-protective immunity conferred by Babesia microti against Babesia rodhaini infection in mice","volume":"80","author":"Li","year":"2012","journal-title":"Infect. Immun."},{"key":"10.1016\/j.actatropica.2023.107069_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.parint.2023.102774","article-title":"In vitro screening of compounds from the Food and Drug Administration-approved library identifies anti-Babesia gibsoni activity of idarubicin hydrochloride and vorinostat","volume":"96","author":"Li","year":"2023","journal-title":"Parasitol. Int."},{"key":"10.1016\/j.actatropica.2023.107069_bib0023","doi-asserted-by":"crossref","first-page":"7950","DOI":"10.1021\/jm901543m","article-title":"Discovery of a 2, 4-diamino-7-aminoalkoxyquinazoline as a potent and selective inhibitor of histone lysine methyltransferase G9a","volume":"52","author":"Liu","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.actatropica.2023.107069_bib0024","doi-asserted-by":"crossref","first-page":"5844","DOI":"10.1021\/jm100478y","article-title":"Protein lysine methyltransferase G9a inhibitors: design, synthesis, and structure activity relationships of 2, 4-diamino-7-aminoalkoxy-quinazolines","volume":"53","author":"Liu","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.actatropica.2023.107069_bib0025","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.vetpar.2018.11.018","article-title":"Inhibitory effects of the phytohormone inhibitors fluridone and inabenfide against Babesia gibsoni in vitro","volume":"265","author":"Liu","year":"2019","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.actatropica.2023.107069_bib0026","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00204-21","article-title":"Tafenoquine is a promising drug candidate for the treatment of babesiosis","volume":"65","author":"Liu","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actatropica.2023.107069_bib0027","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1517\/14740338.2015.989210","article-title":"Cardiac risks associated with antibiotics: azithromycin and levofloxacin","volume":"14","author":"Lu","year":"2015","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.actatropica.2023.107069_bib0028","doi-asserted-by":"crossref","first-page":"16708","DOI":"10.1073\/pnas.1205414109","article-title":"Small-molecule histone methyltransferase inhibitors display rapid antimalarial activity against all blood stage forms in Plasmodium falciparum","volume":"109","author":"Malmquist","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.actatropica.2023.107069_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2021.116018","article-title":"Quest for a potent antimalarial drug lead: synthesis and evaluation of 6, 7-dimethoxyquinazoline-2, 4-diamines","volume":"33","author":"Mizukawa","year":"2021","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.actatropica.2023.107069_bib0030","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1093\/infdis\/jiz119","article-title":"Could the drug tafenoquine revolutionize treatment of Babesia microti infection?","volume":"220","author":"Mordue","year":"2019","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.actatropica.2023.107069_bib0031","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.2174\/092986712799828355","article-title":"Current advances in detection and treatment of babesiosis","volume":"19","author":"Mosqueda","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.actatropica.2023.107069_bib0032","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1128\/AAC.45.12.3293-3303.2001","article-title":"Dicyclic and tricyclic diaminopyrimidine derivatives as potent inhibitors of Cryptosporidium parvum dihydrofolate reductase: structure-activity and structure-selectivity correlations","volume":"45","author":"Nelson","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actatropica.2023.107069_bib0033","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ijpddr.2019.06.004","article-title":"Screening the medicines for malaria venture pathogen box against piroplasm parasites","volume":"10","author":"Nugraha","year":"2019","journal-title":"Int. J. Parasitol Drugs Drug Resist."},{"key":"10.1016\/j.actatropica.2023.107069_bib0034","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1128\/AAC.01526-09","article-title":"Preclinical evaluation of the antifolate QN254, 5-chloro-N\u2032 6\u2032-(2, 5-dimethoxy-benzyl)-quinazoline-2, 4, 6-triamine, as an antimalarial drug candidate","volume":"54","author":"Nzila","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actatropica.2023.107069_bib0035","doi-asserted-by":"crossref","first-page":"6965","DOI":"10.1016\/j.bmc.2014.10.007","article-title":"Synthesis and evaluation of the 2, 4-diaminoquinazoline series as anti-tubercular agents","volume":"22","author":"Odingo","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.actatropica.2023.107069_bib0036","doi-asserted-by":"crossref","first-page":"3711","DOI":"10.1128\/AAC.48.10.3711-3714.2004","article-title":"In vitro activities of 2, 4-diaminoquinazoline and 2, 4-diaminopteridine derivatives against Plasmodium falciparum","volume":"48","author":"Ommeh","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actatropica.2023.107069_bib0037","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1370\/afm.1601","article-title":"Azithromycin and levofloxacin use and increased risk of cardiac arrhythmia and death","volume":"12","author":"Rao","year":"2014","journal-title":"Ann. Fam. Med."},{"key":"10.1016\/j.actatropica.2023.107069_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.parint.2020.102054","article-title":"Closing the empty anti-Babesia gibsoni drug pipeline in vitro using fluorescence-based high throughput screening assay","volume":"75","author":"Rizk","year":"2020","journal-title":"Parasitol. Int."},{"key":"10.1016\/j.actatropica.2023.107069_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/j.vetpar.2019.109013","article-title":"Assay methods for in vitro and in vivo anti-Babesia drug efficacy testing: Current progress, outlook, and challenges","volume":"279","author":"Rizk","year":"2020","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.actatropica.2023.107069_bib0040","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1001\/jama.2016.2884","article-title":"Diagnosis, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: a review","volume":"315","author":"Sanchez","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.actatropica.2023.107069_bib0041","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1128\/CMR.15.3.365-373.2002","article-title":"Cultivation of Babesia and Babesia-like blood parasites: agents of an emerging zoonotic disease","volume":"15","author":"Schuster","year":"2002","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.actatropica.2023.107069_bib0042","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-52176-8","article-title":"Diaminoquinazoline MMV675968 from pathogen box inhibits Acinetobacter baumannii growth through targeting of dihydrofolate reductase","volume":"9","author":"Songsungthong","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.actatropica.2023.107069_bib0043","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01640-17","article-title":"Discovery of new inhibitors of Toxoplasma gondii via the pathogen box","volume":"62","author":"Spalenka","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actatropica.2023.107069_bib0044","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1002\/cmdc.201402098","article-title":"Development of diaminoquinazoline histone lysine methyltransferase inhibitors as potent blood-stage antimalarial compounds","volume":"9","author":"Sundriyal","year":"2014","journal-title":"ChemMedChem"},{"key":"10.1016\/j.actatropica.2023.107069_bib0045","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1039\/C7MD00052A","article-title":"Histone lysine methyltransferase structure activity relationships that allow for segregation of G9a inhibition and anti-Plasmodium activity","volume":"8","author":"Sundriyal","year":"2017","journal-title":"MedChemComm"},{"key":"10.1016\/j.actatropica.2023.107069_bib0046","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1021\/jm500039e","article-title":"Antibacterial activity of a series of N2, N4-disubstituted quinazoline-2, 4-diamines","volume":"57","author":"Van Horn","year":"2014","journal-title":"J. Med. Chemi."},{"key":"10.1016\/j.actatropica.2023.107069_bib0047","doi-asserted-by":"crossref","first-page":"5141","DOI":"10.1021\/jm5000408","article-title":"Antileishmanial activity of a series of N 2, N 4-disubstituted quinazoline-2, 4-diamines","volume":"57","author":"Van Horn","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.actatropica.2023.107069_bib0048","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.vetpar.2006.01.048","article-title":"Chemotherapy against babesiosis","volume":"138","author":"Vial","year":"2006","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.actatropica.2023.107069_bib0049","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1752-153X-7-95","article-title":"Quinazoline derivatives: synthesis and bioactivities","volume":"7","author":"Wang","year":"2013","journal-title":"Chem. Cent. J."},{"key":"10.1016\/j.actatropica.2023.107069_bib0050","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.exppara.2016.07.003","article-title":"Primary Babesia rodhaini infection followed by recovery confers protective immunity against B. \u00e1rodhaini reinfection and Babesia microti challenge infection in mice","volume":"169","author":"Wang","year":"2016","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.actatropica.2023.107069_bib0051","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111611","article-title":"Modulation of peptidases by 2, 4-diamine-quinazoline derivative induces cell death in the amitochondriate parasite Trichomonas vaginalis","volume":"139","author":"Weber","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.actatropica.2023.107069_bib0052","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1128\/JCM.00504-17","article-title":"Babesia microti: from mice to ticks to an increasing number of highly susceptible humans","volume":"55","author":"Westblade","year":"2017","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.actatropica.2023.107069_bib0053","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1086\/508667","article-title":"The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America","volume":"43","author":"Wormser","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.actatropica.2023.107069_bib0054","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1021\/acs.jmedchem.6b01645","article-title":"Discovery of potent and selective inhibitors for G9a-like protein (GLP) lysine methyltransferase","volume":"60","author":"Xiong","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.actatropica.2023.107069_bib0055","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.1016\/j.bmc.2017.06.021","article-title":"Structure-activity relationship studies of G9a-like protein (GLP) inhibitors","volume":"25","author":"Xiong","year":"2017","journal-title":"Bioorg. Med. Chem."}],"container-title":["Acta Tropica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X23002553?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X23002553?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T09:29:21Z","timestamp":1762075761000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001706X23002553"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":55,"alternative-id":["S0001706X23002553"],"URL":"https:\/\/doi.org\/10.1016\/j.actatropica.2023.107069","relation":{},"ISSN":["0001-706X"],"issn-type":[{"value":"0001-706X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-babesial activity of a series of 6,7-dimethoxyquinazoline-2,4-diamines (DMQDAs)","name":"articletitle","label":"Article Title"},{"value":"Acta Tropica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actatropica.2023.107069","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107069"}}